A G-CSF functionalized scaffold for stem cells seeding: a differentiating device for cardiac purposes
- PMID: 20518852
- PMCID: PMC3822623
- DOI: 10.1111/j.1582-4934.2010.01100.x
A G-CSF functionalized scaffold for stem cells seeding: a differentiating device for cardiac purposes
Abstract
Myocardial infarction and its consequences represent one of the most demanding challenges in cell therapy and regenerative medicine. Transfer of skeletal myoblasts into decompensated hearts has been performed through intramyocardial injection. However, the achievements of both cardiomyocyte differentiation and precise integration of the injected cells into the myocardial wall, in order to augment synchronized contractility and avoid potentially life-threatening alterations in the electrical conduction of the heart, still remain a major target to be pursued. Recently, granulocytes colony-stimulating factor (G-CSF) fuelled the interest of researchers for its direct effect on cardiomyocytes, inhibiting both apoptosis and remodelling in the failing heart and protecting from ventricular arrhythmias through the up-regulation of connexin 43 (Cx43). We propose a tissue engineering approach concerning the fabrication of an electrospun cardiac graft functionalized with G-CSF, in order to provide the correct signalling sequence to orientate myoblast differentiation and exert important systemic and local effects, positively modulating the infarction microenvironment. Poly-(L-lactide) electrospun scaffolds were seeded with C2C12 murine skeletal myoblast for 48 hrs. Biological assays demonstrated the induction of Cx43 expression along with morphostructural changes resulting in cell elongation and appearance of cellular junctions resembling the usual cardiomyocyte arrangement at the ultrastructural level. The possibility of fabricating extracellular matrix-mimicking scaffolds able to promote myoblast pre-commitment towards myocardiocyte lineage and mitigate the hazardous environment of the damaged myocardium represents an interesting strategy in cardiac tissue engineering.
© 2011 The Authors Journal of Cellular and Molecular Medicine © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd.
Figures








Similar articles
-
Polyurethane scaffolds seeded with genetically engineered skeletal myoblasts: a promising tool to regenerate myocardial function.Artif Organs. 2010 Feb;34(2):E46-54. doi: 10.1111/j.1525-1594.2009.00937.x. Artif Organs. 2010. PMID: 20420589
-
Construction of skeletal myoblast-based polyurethane scaffolds for myocardial repair.Artif Organs. 2007 Jun;31(6):425-33. doi: 10.1111/j.1525-1594.2007.00385.x. Artif Organs. 2007. PMID: 17537054
-
Colony-stimulating factor-1 transfection of myoblasts improves the repair of failing myocardium following autologous myoblast transplantation.Cardiovasc Res. 2008 Aug 1;79(3):395-404. doi: 10.1093/cvr/cvn097. Epub 2008 Apr 23. Cardiovasc Res. 2008. PMID: 18436538 Free PMC article.
-
New directions in strategies using cell therapy for heart disease.J Mol Med (Berl). 2003 May;81(5):288-96. doi: 10.1007/s00109-003-0432-0. Epub 2003 Apr 16. J Mol Med (Berl). 2003. PMID: 12698252 Review.
-
Skeletal myoblasts and cardiac repair.J Mol Cell Cardiol. 2008 Oct;45(4):545-53. doi: 10.1016/j.yjmcc.2007.11.009. Epub 2007 Dec 4. J Mol Cell Cardiol. 2008. PMID: 18187148 Review.
Cited by
-
Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review.J R Soc Interface. 2015 Jul 6;12(108):20150254. doi: 10.1098/rsif.2015.0254. J R Soc Interface. 2015. PMID: 26109634 Free PMC article. Review.
-
Preliminary In Vivo Evaluation of a Hybrid Armored Vascular Graft Combining Electrospinning and Additive Manufacturing Techniques.Drug Target Insights. 2016 Feb 28;10(Suppl 1):1-7. doi: 10.4137/DTI.S35202. eCollection 2016. Drug Target Insights. 2016. PMID: 26949333 Free PMC article.
-
Small molecule cardiogenol C upregulates cardiac markers and induces cardiac functional properties in lineage-committed progenitor cells.Cell Physiol Biochem. 2014;33(1):205-21. doi: 10.1159/000356663. Epub 2014 Jan 24. Cell Physiol Biochem. 2014. PMID: 24481283 Free PMC article.
-
Mechanical Considerations of Electrospun Scaffolds for Myocardial Tissue and Regenerative Engineering.Bioengineering (Basel). 2020 Oct 3;7(4):122. doi: 10.3390/bioengineering7040122. Bioengineering (Basel). 2020. PMID: 33022929 Free PMC article. Review.
-
Implantation of a Poly-L-Lactide GCSF-Functionalized Scaffold in a Model of Chronic Myocardial Infarction.J Cardiovasc Transl Res. 2017 Feb;10(1):47-65. doi: 10.1007/s12265-016-9718-9. Epub 2017 Jan 23. J Cardiovasc Transl Res. 2017. PMID: 28116550 Free PMC article.
References
-
- Frangogiannis NG. Chemokines in the ischemic myocardium: from inflammation to fibrosis. Inflamm Res. 2004;53:585–95. - PubMed
-
- Chamberlain DA. Overview of completed sudden death trials: European experience. Cardiology. 1987;74:10–23. - PubMed
-
- Demirovic J, Myerburg RJ. Epidemiology of sudden coronary death: an overview. Prog Cardiovasc Dis. 1994;37:39–48. - PubMed
-
- Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation. 1992;85:I2–10. - PubMed
-
- Drexler H, Meyer GP, Wollert KC. Bone-marrow-derived cell transfer after ST-elevation myocardial infarction: lessons from the BOOST trial. Nat Clin Pract Cardiovasc Med. 2006;3:S65–8. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical